To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 120.40 |
Bid | 120.40 |
Ask | 121.80 |
Change | -1.60 (-1.31%) |
Volume | 220,303 |
Open | 122.20 |
High | 122.20 |
Low | 120.20 |
Prev. Close | 122.00 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 652.62m |
Market Capitalisation | £785.75m |
Market Size | 5,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 74 |
---|---|
Vol. Sold | 218,969 |
Sold Value | £264.91k |
Vol. Bought | 1,334 |
Bought Value | £1.63k |
PE Ratio | -14.36754 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
02-May-24 | 13:04:53 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | A Automatic Execution |
02-May-24 | 13:04:37 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | A Automatic Execution |
02-May-24 | 13:04:21 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | O Ordinary Trade was executed as an SI |
02-May-24 | 13:04:05 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | A Automatic Execution |
02-May-24 | 12:49:37 | 120.40 | 1 | Sell* | 120.40 | 121.80 | 1.20 | A Automatic Execution |
02-May-24 | 12:49:31 | 120.40 | 1 | Sell* | 120.40 | 121.80 | 1.20 | A Automatic Execution |
02-May-24 | 12:49:24 | 120.40 | 1 | Sell* | 120.40 | 121.80 | 1.20 | A Automatic Execution |
02-May-24 | 12:41:13 | 121.00 | 30,761 | Sell* | 120.40 | 121.80 | 37.22k | O Ordinary |
02-May-24 | 12:34:33 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | O Ordinary Trade was executed as an SI |
02-May-24 | 12:34:21 | 120.40 | 2 | Sell* | 120.40 | 121.80 | 2.41 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients